Form D · Biotechnology
CardioGenics Inc.
Mississauga, A6 · CIK 0001470449
Offering snapshot reported Aug 17, 2009 · SEC filing
- Reported sold
- $2.72M Offering amount: $2.72M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jul 31, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2009 | Initial | $2,715,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133707
Common Shares
Source: Form D, filed Aug 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Carville | Executive |
| James Essex | Executive |
| Yahia Gawad | Director, Executive |
| Chandra Panchal | Director |
| Alexander Reid | Director |
| Linda J. Sterling | Director, Executive |
| J. Neil Tabatznik | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6295 Northam Drive Unit 8
Mississauga, A6, L4V 1W8
Mississauga, A6, L4V 1W8